![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » HealPros Secures Round of Series A Funding
HealPros Secures Round of Series A Funding
![](https://www.fdanews.com/ext/resources/test/Device_Images3/moneyinhand.gif?t=1435858774&width=430)
December 28, 2015
HealPros has closed a round of Series A funding to expand its mobile diabetic retinopathy program into at least 25 states in 2016.
The funding — the value of which was not disclosed — was led by New York-based Sopris Capital.
HealPros is a provider of mobile diabetic retinopathy examinations on behalf of healthcare payers across the U.S. — Michael Cipriano
Upcoming Events
-
21Oct